Search PubMed⌕ Search

Biomedical subjects

W Kawiak

Publications and source records attributed to W Kawiak.

At least 55 records · Page 3Linked to original sources
PubMedDate not supplied

[Effect of low-molecular dextran on leukergy and thrombergy in cases of cerebral infarct].

In cases of thrombotic cerebral infarction the leucergic and thrombergic tests were done on the 2nd and 3d days of the disease and after 48 hours from the first dextran loading. Fleck's test tube method was used in the leucergy test. The proportion of agglutinated platelets was calculated from a smear stained by Papanicolau method. The results were processed statistically. An inhibitory effect of dextran on aggregation of white blood cells and platelets was observed in the blood of patients with cerebral infarction. The inhibitory effects of dextran was greater in relation to aggregation of platelets than white blood cells. However, in our investigations the effect of this agent on both processes was transient.

Aged↗
PubMedDate not supplied

[Catalase-like activity in cerebrospinal fluid in patients with cerebral stroke].

Catalase-like activity was determined in the cerebrospinal fluid of 16 patients with cerebral haemorrhage, 24 cases od encephalomalacia due to thrombosis, and 10 controls. It was demonstrated that catalase-like activity in the cerebrospinal fluid of patients with cerebral stroke is significantly raised in relation to the activity observed in controls. This rise is patricularly evident in the first 24 hours after the onset. The rise was statistically significant only in the group of encephalomalacia.

Catalase↗
PubMedDate not supplied

[Venous blood concentration of pyruvates in patients with stroke].

The concentration of pyruvate in the venous blood of 31 patients with stroke was determined by the enzymatic spectrophotometric method. The pyruvate concentration was raised on the 1st, 3rd and 10th days after stroke and this increase was statistically significant. Pyruvate concentration changes in venous blood were associated with severe clinical condition of the patients.

Adult↗
PubMedDate not supplied

[Effect of piracetam on inorganic phosphates and phospholipids in the blood of patients with cerebral infarction in the earliest period of the disease].

The influence of piracetam on the level of inorganic and phospholipid phosphorus in blood of ischemic stroke patients was evaluated. In healthy patients piracetam (2G, i.v.) diminished the concentration of inorganic phosphorus and essentially lowered the content of ion connected with phospholipids. In stroke patients inorganic phosphorus was primarily enhanced and organic lowered. Treatment with piracetam lowered the concentration of both inorganic and phospholipid phosphorus in blood.

Acute Disease↗
PubMedDate not supplied

[Effect of long-term administration of low-molecular dextran (40,000) on the blood levels of inorganic phosphorus and lipid-bound phosphorus in patients with cerebral infarction].

The effect of low-molecular dextran given on 6 days after cerebral infarction onset on the content of inorganic phosphorus and lipid-bound phosphorus was studied in 22 patients. The obtained results were compared with those in a control group. Low-molecular dextran caused a statistically significant decrease of the serum lipid-bound phosphorus level in healthy subjects and in patients, which was most pronounced on the sixth day of successive dextran administration, while it had no effect on serum inorganic phosphorus in the studied subjects.

Aged↗